| scholarly article | Q13442814 |
| P50 | author | Mazen Haydar | Q87530662 |
| P2093 | author name string | Joseph J Naoum | |
| Mark G Davies | |||
| Alan B Lumsden | |||
| Eric K Peden | |||
| Jean Bismuth | |||
| Hosam F El-Sayed | |||
| Tiffany K Street | |||
| Mitul S Patel | |||
| Nibal R Chamoun | |||
| P2860 | cites work | Some considerations about the hypercoagulable states and their treatments. | Q50544682 |
| Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy | Q70054580 | ||
| Diabetes, a Hypercoagulable State? Haemostatic Variables in Newly Diagnosed Type 2 Diabetic Patients | Q72778419 | ||
| Influence of reduced nicotinamide adenine dinucleotide on the production of interleukin-6 by peripheral human blood leukocytes | Q77643901 | ||
| Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery | Q81530809 | ||
| Diabetes mellitus and the incidence of deep vein thrombosis after total knee arthroplasty: a retrospective study | Q85444391 | ||
| The use of lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia during major vascular surgery | Q31834585 | ||
| Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up. | Q33332910 | ||
| Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells | Q33340783 | ||
| The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment | Q33364938 | ||
| Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes | Q33375029 | ||
| Beyond the platelet count: heparin antibodies as independent risk predictors | Q33375433 | ||
| Thrombotic events in patients with antiplatelet factor 4/heparin antibodies | Q33384727 | ||
| Profiling of heparin-induced thrombocytopenia antibody levels in patients with and without diabetes | Q33388783 | ||
| Heparin-induced thrombocytopenia: present and future | Q33394188 | ||
| Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation | Q33394429 | ||
| Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q33399580 | ||
| Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician | Q33402572 | ||
| Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia | Q33406904 | ||
| The clinical significance and risk factors of anti-platelet factor 4/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up | Q33407497 | ||
| Platelet aggregating activity in the plasma of patients with established thrombosis | Q33416573 | ||
| Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes | Q33827427 | ||
| Diabetes mellitus: a hypercoagulable state | Q34190414 | ||
| Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. | Q34733351 | ||
| Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis | Q35065353 | ||
| Hereditary and acquired thrombophilic disorders complicating vascular access in haemodialysis: O. Sarkar et al | Q35574239 | ||
| Type 2 diabetes: an atherothrombotic syndrome | Q36126667 | ||
| Venous thromboembolism in patients with diabetes mellitus | Q36178744 | ||
| ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul | Q36426489 | ||
| Platelet factor 4/heparin antibody (IgG/M/A) in healthy subjects: a literature analysis of commercial immunoassay results | Q36710996 | ||
| Platelet and coagulation factors in proliferative diabetic retinopathy | Q37183198 | ||
| Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study | Q37326883 | ||
| Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. | Q44173270 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 649652 | |
| P577 | publication date | 2014-02-06 | |
| P1433 | published in | Thrombosis | Q26842403 |
| P1476 | title | Elevated heparin-induced antibodies are more common in diabetic patients with vascular disease | |
| P478 | volume | 2014 |
| Q33443580 | Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera. |
| Q93010476 | Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes |
| Q57463193 | Significant association of anti-platelet factor 4/heparin antibody with cardiovascular disease in hemodialysis patients: a longitudinal 7-year study |
Search more.